Events and Conferences

Contact Veristat Now

Request A Proposal

Contact Us

Veristat will attend the JP Morgan Healthcare Summit and Biotech Showcase 2016

December 30, 2015

Join Veristat and the world’s leading biotechnology and life sciences firms at one of the industry’s largest annual healthcare investor events of 2016.

Read More

Veristat to Exhibit at the CDISC International Interchange Conference

October 29, 2015

Join Veristat at the 2015 CDISC International Interchange conference which is themed "Smarter Research to Unlock Cures".  

Read More

Veristat to Attend the Chief Medical Officer Summit West

October 29, 2015

Join Veristat at the 3rd Annual Chief Medical Officer Summit West, which is said to be “the only conference of its kind dedicated to addressing the unique challenges faced by CMOs in emerging biotechnology firms”.

Read More

Veristat to Exhibit at Outsourcing in Clinical Trials Southern California

October 12, 2015

Visit Veristat Booth #8 at the Outsourcing in Clinical Trials Southern California Conference

Read More

Veristat to Speak at MAGI's Clinical Research Conference 2015 West

October 8, 2015

Learn How to Work Smarter With your Clinical Research Partners at MAGI 2015

Read More

Veristat to Exhibit at "Outsourcing in Clinical Trials New England" Conference

September 11, 2015

Veristat is excited to attend and exhibit at the upcoming Outsourcing in Clinical Trials New England conference, taking place on September 16-17, 2015 in Boston, MA.   We encourage you to stop by our booth to speak with our experts about your current needs and challenges.

Read More

Veristat to Talk on “Use of Biomarkers in Clinical Development & Regulatory Submission” at MassBio Forum.

July 29, 2015

Veristat’s President and Chief Biostatistician, John P. Balser, PhD will moderate the second in a two-part series of panel discussions on Biomarkers at the upcoming MassBio Forum taking place on Tuesday, August 4, 2015 from 8:00-10:00 AM.   This second forum will focus on the use of biomarkers in clinical development, with specific discussion on clinical study design, patient selection, statistical analysis, and the regulatory challenges with using biomarkers.

The panel will explore the following:

Read More